COLUMBIA, Md.--(BUSINESS WIRE)--CELSION CORPORATION (NASDAQ: CLN) announced today that its docetaxel thermosensitive liposome preclinical study results will be presented at the 11th Liposome Research Days Conference. This LRD (Liposome Research Days) conference will be held from July 19 - 22, 2008 in Yokohama, Japan.
